{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:40:27Z","timestamp":1768977627652,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T00:00:00Z","timestamp":1470960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.vaccine.2016.08.032","type":"journal-article","created":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T01:07:17Z","timestamp":1472519237000},"page":"4979-4984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Factors determining anti-poliovirus type 3 antibodies among orally immunised Indian infants"],"prefix":"10.1016","volume":"34","author":[{"given":"Saravanakumar Puthupalayam","family":"Kaliappan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasan","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidhartha","family":"Giri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira","family":"Praharaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun S.","family":"Karthikeyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhir","family":"Babji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayaprakash","family":"Muliyil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Grassly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gagandeep","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.08.032_b0005","unstructured":"World Health Organization. World Health Organization Poliomyelitis Fact sheet no.114; 2016. <http:\/\/www.who.int\/mediacentre\/factsheets\/fs114\/en\/> [accessed February 10, 2016]."},{"issue":"1","key":"10.1016\/j.vaccine.2016.08.032_b0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00970.x","article-title":"Immunology of gut mucosal vaccines","volume":"239","author":"Pasetti","year":"2011","journal-title":"Immunol Rev"},{"issue":"5","key":"10.1016\/j.vaccine.2016.08.032_b0015","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review","volume":"13","author":"Patriarca","year":"1991","journal-title":"Rev Infect Dis"},{"issue":"9953","key":"10.1016\/j.vaccine.2016.08.032_b0020","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(14)60934-X","article-title":"Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial","volume":"384","author":"John","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.08.032_b0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1741-7007-8-129","article-title":"Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine","volume":"8","author":"Levine","year":"2010","journal-title":"BMC Biol"},{"issue":"9","key":"10.1016\/j.vaccine.2016.08.032_b0030","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ni0910-769","article-title":"Improving the performance of enteric vaccines in the developing world","volume":"11","author":"Serazin","year":"2010","journal-title":"Nat Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2016.08.032_b0035","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1093\/infdis\/175.Supplement_1.S258","article-title":"The effect of diarrhea on oral poliovirus vaccine failure in Brazil","volume":"175","author":"Posey","year":"1997","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2016.08.032_b0040","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/infdis\/jis241","article-title":"Waning intestinal immunity after vaccination with oral poliovirus vaccines in India","volume":"205","author":"Grassly","year":"2012","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2016.08.032_b0045","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/infdis\/jiu182","article-title":"Influence of enteric infections on response to oral poliovirus vaccine: a systematic review and meta-analysis","volume":"210","author":"Parker","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.032_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(16)30023-8","article-title":"The effect of azithromycin on the immunogenicity of oral poliovirus vaccine: a double-blind randomised placebo-controlled trial in seronegative Indian infants","author":"Grassly","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2016.08.032_b0055","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4269\/ajtmh.2012.11-0743","article-title":"Enteropathies in the developing world: neglected effects on global health","volume":"86","author":"Prendergast","year":"2012","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.032_b0060","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1473-3099(11)70190-6","article-title":"Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6\u20139 months in Moradabad, India: a community-based, randomised controlled trial","volume":"12","author":"Estivariz","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.032_b0065","unstructured":"World Health Organization. Manual of laboratory methods for testing of vaccines used in the WHO Expanded Programme on Immunization. In: Report no.: WHO\/VSQ\/97.04. Geneva, Switzerland: World Health Organization; 1997."},{"key":"10.1016\/j.vaccine.2016.08.032_b0070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0277-9536(97)00148-2","article-title":"Context, composition and heterogeneity: using multilevel models in health research","volume":"46","author":"Duncan","year":"1998","journal-title":"Soc. Sci. Med."},{"issue":"4 Suppl. 1","key":"10.1016\/j.vaccine.2016.08.032_b0075","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jegh.2015.06.004","article-title":"Achieving high seroprevalence against polioviruses in Sri Lanka-Results from a serological survey, 2014","volume":"5","author":"Gamage","year":"2015","journal-title":"J Epidemiol Glob Health"},{"issue":"6013","key":"10.1016\/j.vaccine.2016.08.032_b0080","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/bmj.1.6013.812","article-title":"Antibody response of infants in tropics to five doses of oral polio vaccine","volume":"1","author":"John","year":"1976","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.vaccine.2016.08.032_b0085","first-page":"91","article-title":"Antibody response to pulse polio immunization in Aligarh","volume":"42","author":"John","year":"2005","journal-title":"Indian Pediatr"},{"issue":"10","key":"10.1016\/j.vaccine.2016.08.032_b0090","first-page":"1040","article-title":"Antibody levels against polioviruses in children following pulse polio immunization program","volume":"41","author":"Hasan","year":"2004","journal-title":"Indian Pediatr"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2016.08.032_b0095","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1093\/infdis\/jiu204","article-title":"Assessing population immunity in a persistently high-risk area for wild poliovirus transmission in India: a serological study in Moradabad, Western Uttar Pradesh","volume":"210","author":"Deshpande","year":"2014","journal-title":"J Infect Dis"},{"issue":"50","key":"10.1016\/j.vaccine.2016.08.032_b0100","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1016\/j.vaccine.2010.09.069","article-title":"Serologic testing to verify the immune status of internationally adopted children against vaccine preventable diseases","volume":"28","author":"Staat","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2016.08.032_b0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/1596-4078.171383","article-title":"Assessing the impact of polio eradication initiative and routine immunization in Zamfara State, North-West, Nigeria","volume":"15","author":"Yusuf","year":"2015","journal-title":"Nigerian J Health Sci"},{"issue":"12","key":"10.1016\/j.vaccine.2016.08.032_b0110","first-page":"1414","article-title":"Survey of poliovirus antibodies in Kano","volume":"32","author":"Iliyasu","year":"2014","journal-title":"Northern Nigeria. Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.032_b0115","first-page":"168","article-title":"Seroepidemiology of poliomyelitis in Mexico","volume":"34","author":"Ruiz-G\u00f3mez","year":"1992","journal-title":"Salud Publica Mex"},{"issue":"5","key":"10.1016\/j.vaccine.2016.08.032_b0120","doi-asserted-by":"crossref","first-page":"650","DOI":"10.4269\/ajtmh.1998.58.650","article-title":"A population-based seroprevalence study in South Africa as a tool in the polio eradication initiative","volume":"58","author":"Schoub","year":"1998","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.032_b0125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/tropej\/fmi075","article-title":"Neutralizing antibodies against poliovirus serotypes among children in Southwest Nigeria","volume":"52","author":"Adewumi","year":"2006","journal-title":"J Trop Pediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2016.08.032_b0130","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1017\/S0950268802007781","article-title":"Age-specific seroprevalence of poliomyelitis, diphtheria and tetanus antibodies in Spain","volume":"129","author":"Pachon","year":"2002","journal-title":"Epidemiol Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.032_b0135","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0035-9203(77)90075-X","article-title":"Seroepidemiology of the poliovirus in Monrovia (Liberia)","volume":"71","author":"Rodriguez-Burgos","year":"1977","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.032_b0140","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4314\/ajcem.v12i2.64321","article-title":"Evaluation of immunity against poliovirus serotypes among children in Riverine areas of Delta State, Nigeria","volume":"12","author":"Donbraye","year":"2011","journal-title":"African J Clin Exp Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.08.032_b0145","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/jmv.23228","article-title":"A survey for neutralizing antibodies to the three types of poliovirus among children in Maiduguri, Nigeria","volume":"84","author":"Baba","year":"2012","journal-title":"J Med Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2016.08.032_b0150","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1128\/CVI.00092-13","article-title":"Seroprevalence of antipolio antibodies among children <15 years of age in border provinces in China","volume":"20","author":"Wang","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.032_b0155","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/ije\/dyh005","article-title":"The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study","volume":"33","author":"Aaby","year":"2004","journal-title":"Int J Epidemiol"},{"issue":"22","key":"10.1016\/j.vaccine.2016.08.032_b0160","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1016\/j.vaccine.2006.03.038","article-title":"Age-specific changes in the female-male mortality ratio related to the pattern of vaccinations: an observational study from rural Gambia","volume":"24","author":"Aaby","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.032_b0165","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12879-015-0898-8","article-title":"Gender-specific mortality in DTP-IPV- and MMR+\/-MenC-eligible age groups to determine possible sex-differential effects of vaccination: an observational study","volume":"15","author":"Schurink-van\u2019t Klooster","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.032_b0170","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/cid\/cit209","article-title":"Heterologous (\u201cnonspecific\u201d) and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanisms","volume":"57","author":"Flanagan","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2016.08.032_b0175","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/cid\/civ617","article-title":"The effect of oral polio vaccine at birth on infant mortality: a randomized trial","volume":"61","author":"Lund","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"27","key":"10.1016\/j.vaccine.2016.08.032_b0180","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1016\/j.vaccine.2007.04.022","article-title":"Survey of poliovirus antibodies during the final stage of polio eradication in Egypt","volume":"25","author":"El-Sayed","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.032_b0185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.26719\/2015.21.2.83","article-title":"Seroprevalence of poliovirus antibodies among 7-month-old infants after 4 doses of oral polio vaccine in Sistan-va-Baluchestan, Islamic Republic of Iran","volume":"21","author":"Izadi","year":"2015","journal-title":"East Mediterr Health J"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2016.08.032_b0190","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1093\/infdis\/jit492","article-title":"Cross-sectional serologic assessment of immunity to poliovirus infection in high-risk areas of northern India","volume":"210","author":"Bahl","year":"2014","journal-title":"J Infect Dis"},{"issue":"15","key":"10.1016\/j.vaccine.2016.08.032_b0195","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.vaccine.2013.02.003","article-title":"A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan","volume":"31","author":"Habib","year":"2013","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T11:16:07Z","timestamp":1556363767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16307046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":39,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0264410X16307046"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors determining anti-poliovirus type 3 antibodies among orally immunised Indian infants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}